MAP1 Antikörper (AA 337-351)
Kurzübersicht für MAP1 Antikörper (AA 337-351) (ABIN636277)
Target
Alle MAP1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 337-351
-
Aufreinigung
- Affinity chromatography purified
-
Immunogen
- MAP1 antibody was raised in rabbit using AA 337-351 EEEALLQAILEGNFT of the human MAP-1 protein as the immunogen.
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- MAP1 (Mannosidase Processing 1 (MAP1))
-
Andere Bezeichnung
- MAP1
-
Hintergrund
- A novel Bax-associating protein, named MAP-1 (Modulator of Apoptosis), mediates caspase-dependent apoptosis in mammalian cells when overexpressed. MAP-1 homodimerizes and associates with the proapoptotic Bax and the prosurvival Bcl-2 and Bcl-X(L) of the Bcl-2 family in vitro and in vivo in mammalian cells.
-
Pathways
- Positive Regulation of Endopeptidase Activity
Target
-